力诺药包：10月31日召开董事会会议

Company Overview - Linuo Pharmaceutical (SZ 301188) announced the convening of its 16th meeting of the 4th Board of Directors on October 31, 2025, to discuss the election of the chairman and changes to the legal representative [1] - For the first half of 2025, Linuo Pharmaceutical reported that its revenue composition was 100% from the manufacturing sector [1] - As of the report date, Linuo Pharmaceutical has a market capitalization of 4.1 billion yuan [1] Industry Context - The news highlights a broader issue in the energy sector, where multiple regions are experiencing "negative electricity prices," raising questions about why power plants are reluctant to shut down despite not making profits from electricity sales [1]